Argitalpenak (46) Ikertzaileren baten partaidetza izan duten argitalpenak

2013

  1. Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel

    Anti-Cancer Drugs, Vol. 24, Núm. 10, pp. 1084-1092

  2. Adjuvant bevacizumab: Positive data from a negative trial

    The Lancet Oncology

  3. Anales de Pediatría: The past, the present and the future

    Anales de Pediatria, Vol. 79, Núm. 5, pp. 277-278

  4. Anales de Pediatría: ayer, hoy y mañana

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 79, Núm. 5, pp. 277-278

  5. Bevacizumab in advanced breast cancer: A new model for the assessment of activity in non-first-line treatment regimens

    Anti-Cancer Drugs, Vol. 24, Núm. 9, pp. 975-979

  6. Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

    British Journal of Cancer, Vol. 108, Núm. 5, pp. 1052-1060

  7. Bone metastases: Causes, consequences and therapeutic opportunities

    European Journal of Cancer, Supplement

  8. Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: A randomized, double-blind, placebo-controlled phase III study

    Oncologist, Vol. 18, Núm. 3, pp. 257-264

  9. Circulating tumour cells and cell-free DNA as tools for managing breast cancer

    Nature Reviews Clinical Oncology, Vol. 10, Núm. 7, pp. 377-389

  10. Clinical, biochemical, and neuroimaging findings predict long-term neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection

    Journal of Pediatrics, Vol. 163, Núm. 3

  11. Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2

    International Journal of Cancer, Vol. 133, Núm. 10, pp. 2315-2324

  12. Current situation: Lower genital tract pathology and colposcopy training in spanish gynecology and obstetrics residents

    Journal of Lower Genital Tract Disease, Vol. 17, Núm. 1, pp. 12-16

  13. D. Torrejon, J. Cortes, D. Serpico, S. Di Cosimo à l'article de F. Vasseur et al.: KI67 chez les patientes jeunes présentant un cancer du sein. Gynecol Obstet Fertil 2013; 41(1):16-9

    Gynecologie Obstetrique et Fertilite

  14. Dasatinib plus capecitabine for advanced breast cancer: Safety and efficacy in phase I study CA180004

    Clinical Cancer Research, Vol. 19, Núm. 7, pp. 1884-1893

  15. Detección de protozoos parásitos entéricos, bacteriófagos de E. coli y organismos indicadores de contaminación en camarones comercializados en el estado Zulia

    Kasmera, Vol. 41, Núm. 1, pp. 16-26

  16. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    Circulation, Vol. 128, Núm. 14, pp. 1495-1503

  17. Episodio aparentemente letal neonatal durante el «piel con piel». Tratamiento con hipotermia

    Anales de Pediatria, Vol. 79, Núm. 4, pp. 253-256

  18. Episodio aparentemente letal neonatal durante el «piel con piel»: Tratamiento con hipotermia

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 79, Núm. 4, pp. 253-256

  19. Exposure-response analysis of pertuzumab in HER2-positive metastatic breast cancer: Absence of effect on QTc prolongation and other ECG parameters

    Cancer Chemotherapy and Pharmacology, Vol. 72, Núm. 5, pp. 1133-1141

  20. First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: Pooled and subgroup analyses of data from 2447 patients

    Annals of Oncology, Vol. 24, Núm. 11, pp. 2773-2780